Trial Profile
A Retrospective Study Assessing Clinical Outcomes of Salvage Lenvatinib Therapy in Patients with Metastatic Anaplastic Thyroid Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2018
Price :
$35
*
At a glance
- Drugs Lenvatinib (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 10 May 2018 New trial record